Online weight loss treatment in New Mexico
Surfbound connects eligible adults in New Mexico with licensed providers for online GLP-1 weight-loss treatment review. Semaglutide $169/mo and tirzepatide $219/mo. Prescriptions are not guaranteed and are issued only when medically appropriate.
No in-person visit. A licensed provider reviews your intake. A prescription is not guaranteed.
Can I start online GLP-1 weight loss treatment in New Mexico?
Yes. Eligible adults across New Mexico can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. A licensed provider credentialed in New Mexico reviews your health intake and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your New Mexico address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
The Land of Enchantment · Southwest region. High obesity rates and rural access gaps, with progressive telehealth policy. Online review reaches Albuquerque to rural New Mexico.
Cities in New Mexico
Coverage across New Mexico
Surfbound lists 4 New Mexico cities with a dedicated local page. Care is delivered online, so you can also start from anywhere else in the state.
Provider access & processPricing and insurance
Semaglutide is $169/mo and tirzepatide is $219/mo. Clear pricing shown before checkout. Surfbound does not accept insurance at this time.
Shipping to New Mexico
After provider approval, a licensed compounding pharmacy prepares and dispatches the order. For New Mexico addresses, from Albuquerque, Santa Fe, Las Cruces to smaller communities, transit time depends on distance from the dispensing pharmacy, the pharmacy's processing day, weekends and carrier volume — tracking is emailed once the package is with the carrier.
What's included in every New Mexico plan
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. There is no separate membership fee.
New Mexico coverage & access
Practical answers about where you can start, how shipping works, and how to compare complete costs in New Mexico. The New Mexico provider access & process page covers the clinical steps in detail.
Surfbound lists 4 New Mexico cities with a dedicated local page. Because care is delivered online, you can start from anywhere in New Mexico — the city list is a navigation aid, not a limit on where you can begin.
The New Mexico telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in New Mexico. You complete a health intake online, and a licensed provider credentialed in New Mexico reviews your information remotely.
New Mexico permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in New Mexico may review a New Mexico patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in New Mexico” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active New Mexico license issued by the New Mexico Medical Board, and any pharmacy filling your prescription must be licensed in New Mexico. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in New Mexico” section on this page.
Compounded semaglutide is $169/mo and compounded tirzepatide is $219/mo for New Mexico patients, with the provider review included and no separate membership fee. Pricing is shown before checkout, and compounded medications are not FDA-approved.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
Not guaranteed anywhere in New Mexico. The New Mexico-licensed provider can approve, request more information, or decline after reading your intake.
Switching to Surfbound is possible across New Mexico. Enter your current medication and dose in the doctor-notes field; the New Mexico-licensed provider decides whether to continue at that dose or adjust it, and no written quote is needed.
For New Mexico patients, the honest comparison is all-in monthly cost at the same dose. The GLP-1 total-cost calculator normalises membership, shipping and titration fees against one flat published rate.
Patients in New Mexico can be reviewed for compounded semaglutide. The review, the medication if prescribed, and delivery are covered by one published monthly price. Compounded semaglutide is not FDA-approved.
Yes. Compounded tirzepatide — a dual GIP/GLP-1 receptor agonist — is offered across New Mexico at a flat monthly rate with no dose-based upcharge. A New Mexico-licensed provider determines whether it is medically appropriate, and the pharmacy ships if prescribed. It is not FDA-approved.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and New Mexico residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the New Mexico-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in New Mexico. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed New Mexico provider approves your medication. High obesity rates and rural access gaps, with progressive telehealth policy.
Yes. New Mexico residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed New Mexico provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across New Mexico with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. A New Mexico-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. New Mexico residents complete a short online intake on their own schedule, and a New Mexico-licensed provider reviews it remotely. If prescribed, medication ships to your door — no clinic, waiting room, or daytime appointment. High obesity rates and rural access gaps, with progressive telehealth policy. Online review reaches Albuquerque to rural New Mexico.
Yes. Men across New Mexico begin with a private online intake, a licensed New Mexico provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches New Mexico residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Telehealth rules in New Mexico
What governs a provider treating a New Mexico patient online, and where you can check it yourself.
State medical board
New Mexico Medical BoardNew Mexico Medical Board licenses the providers who review New Mexico intakes. The board site carries the current licensing and practice requirements.
Telehealth statute or rule
New Mexico Telehealth Act (NMSA 1978, §§ 24-27-1 to 24-27-8)Opens the official New Mexico code. Search the statute or rule named above for the full text rather than relying on any summary.
Licensure requirement
A clinician must hold an active New Mexico license to evaluate or treat a patient who is physically located in New Mexico. Every New Mexico intake is routed to a provider credentialed in New Mexico, and a prescription is issued only when that provider determines treatment is medically appropriate.
New Mexico has been a national leader in telehealth adoption, with progressive policies supporting remote care delivery. The state permits asynchronous telemedicine and prescribing when a proper provider-patient relationship exists.
Surfbound is an online service. We do not have physical offices in New Mexico. Licensed providers review health information online. A prescription is not guaranteed.
Medical sources & references
Surfbound providers are licensed to practice in New Mexico and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official New Mexico state government agency. Provider licensure in New Mexico is governed by the New Mexico Medical Board.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.